Analyses / JPM
Large-cap bank trading mid-range after a down day. Strong margins and low trailing P/E, offset by slow revenue growth and insider net selling by count.
A free account reveals JPM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Trailing P/E of 13.2x and P/B of 2.4x sit at a modest multiple for a bank with a 35.9% operating margin and 29.3% net margin. EPS growth of 17.4% (TTM) and 16.8% (5Y) is strong. Dividend yield of 2.7% is covered by a 29.1% payout ratio. If the stock reclaims the prior close near 330 and the 52-week high of 366.5 comes back into view, the current discount to that range could narrow. Beta of 1.05 suggests market-like sensitivity.
▼ Bear Case
Revenue growth is slow at 3.4% (TTM) versus 7.7% (5Y), so earnings growth may rely on margins or one-off factors. Forward P/E of 15.2x sits above trailing 13.2x, which implies lower expected earnings per share; this conflicts with the positive EPS growth figure and needs reconciling. Price-to-FCF of 67x suggests weak free cash flow conversion. Insider activity shows 108 sell transactions versus 90 buys. The stock fell 1.8% on the day and sits about 51% up its 52-week range.
Valuation
FAIRLY VALUED — score 55/100
Low trailing multiples and high margins are offset by slow revenue growth, a high price-to-FCF multiple and an unreconciled forward P/E.
Technical Levels
Support · $323.71 (Day low) · $327.52 (Day open) · $279.10 (52-week low)
Resistance · $329.96 (Prior close) · $330.09 (Day high) · $366.50 (52-week high)
RSI: Not available in payload
Financial Health
Score 55/100. Payout ratio is moderate and beta is near market. Standard leverage and liquidity ratios are not in the payload, and bank balance sheets need bank-specific metrics not provided here.
Catalysts
| CFO transition: Bregje de Best named next CFO | Recent (news dated in payload) | medium |
| Fed rate path and political risk commentary (Fed Chair Kevin Warsh, Senate control) | Ongoing | high |
| Quarterly earnings report (date not in payload) | Not provided | high |
Risk Flags
See JPM's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock JPM free →Recent News
- Analysts bullish on Airtel Money as mobile payments drive growthYahoo
- What State Street Financial SPDR ETF (XLF) Sold: Berkshire Leads on TuesdayYahoo
- JPMorgan Chase faces fresh scrutiny after banking disruptionYahoo
- iQIYI (IQ) Stock Sees Fair Value Cut After Analysts Lower TargetsYahoo
- Fed Chair Kevin Warsh Vowed to Hit the Fed's 2% Inflation Target After October's Rate Hold, Even as JPMorgan Warns Democratic Control of the Senate Could Make Him a One-Term Chair. Here's Why That Political Risk Matters for Markets.Yahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full JPM analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
JPM FAQ
Is JPM a buy right now?
JPMorgan Chase & Co.'s current read is a Mid-range consolidation, quality value watchlist setup with medium confidence over a 3 to 6 months horizon. Valuation: FAIRLY VALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is JPM overvalued?
FAIRLY VALUED (valuation score 55/100). Low trailing multiples and high margins are offset by slow revenue growth, a high price-to-FCF multiple and an unreconciled forward P/E.
What are the risks of buying JPM?
Revenue growth is slow at 3.4% (TTM) versus 7.7% (5Y), so earnings growth may rely on margins or one-off factors. Forward P/E of 15.2x sits above trailing 13.2x, which implies lower expected earnings per share; this conflicts with the positive EPS growth figure and needs reconciling. Price-to-FCF of 67x suggests weak free cash flow conversion. Insider activity shows 108 sell transactions versus 90 buys. The stock fell 1.8% on the day and sits about 51% up its 52-week range.